tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

REGN Stock Latest News

Dupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
Press ReleasesDupixent® (dupilumab) Approved in the European Union as the First-ever Targeted Therapy for Patients with COPD
5h ago
REGN
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
PremiumPress Releases
Odronextamab Recommended for EU Approval by the CHMP to Treat Relapsed/Refractory Follicular Lymphoma and Diffuse Large B-cell Lymphoma
5d ago
REGN
Regeneron announces positive CHMP opinion for odronextamab
PremiumThe Fly
Regeneron announces positive CHMP opinion for odronextamab
5d ago
REGN
Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
PremiumPress Releases
Regeneron to Report Second Quarter 2024 Financial and Operating Results and Host Conference Call and Webcast on August 1, 2024
6d ago
REGN
Verona approval label may benefit Regeneron, says RBC Capital
PremiumThe Fly
Verona approval label may benefit Regeneron, says RBC Capital
6d ago
REGN
VRNA
Dupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
PremiumPress ReleasesDupixent® (dupilumab) Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine
7d ago
REGN
Regeneron/Sanofi announce NEJM publication of Dupixent Phase 3 EoE results
PremiumThe Fly
Regeneron/Sanofi announce NEJM publication of Dupixent Phase 3 EoE results
7d ago
SNY
REGN
Intellia reports proof-of-concept data for redosing CRISPR-based therapy
PremiumThe Fly
Intellia reports proof-of-concept data for redosing CRISPR-based therapy
8d ago
NTLA
REGN
Regeneron price target raised to $1,170 from $1,060 at Argus
PremiumThe Fly
Regeneron price target raised to $1,170 from $1,060 at Argus
8d ago
REGN
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
PremiumStock Analysis & Ideas
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
13d ago
REGN
Regeneron presents follow-up data from pivotal Phase 1/2 LINKER-MM1 trial
PremiumThe Fly
Regeneron presents follow-up data from pivotal Phase 1/2 LINKER-MM1 trial
17d ago
REGN
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
PremiumPress Releases
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma
17d ago
REGN
REGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet?
PremiumStock Analysis & IdeasREGN, CI, BSX: Which “Strong Buy” Healthcare Stock Is the Best Bet?
20d ago
CI
BSX
Regeneron price target raised to $1,229 from $1,200 at RBC Capital
PremiumThe Fly
Regeneron price target raised to $1,229 from $1,200 at RBC Capital
21d ago
REGN
Regeneron price target raised to $1,125 from $1,050 at Wells Fargo
PremiumThe Fly
Regeneron price target raised to $1,125 from $1,050 at Wells Fargo
21d ago
REGN
VTRS
Mylan injunction an ‘incremental positive’ for Regeneron, says Morgan Stanley
PremiumThe Fly
Mylan injunction an ‘incremental positive’ for Regeneron, says Morgan Stanley
22d ago
REGN
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
PremiumPress Releases
Kevzara® (sarilumab) Approved by FDA for the Treatment of Active Polyarticular Juvenile Idiopathic Arthritis (pJIA)
22d ago
REGN
Regeneron, Sanofi announce FDA approved Kevzara for treatment of pJIA
PremiumThe Fly
Regeneron, Sanofi announce FDA approved Kevzara for treatment of pJIA
22d ago
SNY
REGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
27d ago
EQ
AFMD
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
28d ago
AFMD
BPTH
Regeneron price target raised to $1,200 from $1,185 at RBC Capital
PremiumThe Fly
Regeneron price target raised to $1,200 from $1,185 at RBC Capital
29d ago
AZN
AMGN
FibroGen, Regeneron in deal for oncology assets in evaluation combo study
PremiumThe Fly
FibroGen, Regeneron in deal for oncology assets in evaluation combo study
30d ago
FGEN
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >